In Brief: The Liposome Company
Executive Summary
The Liposome Company: Brian Geiger to VP and chief financial officer. Geiger joins from 23 years at J&J. He succeeds Brooks Boveroux who is named VP-investor relations as part of a reorganization of the company's financial function. The amphotericin B lipid complex Abelcet recently completed its first quarter of sales...